A simple genetic system has been developed to test the effect of over-expression of wild-type or mutated human MutL homologue 1 (hMLH1) proteins on methyl-directed mismatch repair (MMR) in Escherichia coli. The system relies on detection of Lac + revertants using MMR-proficient or MMR-deficient E. coli strains carrying a lac j1 frameshift mutation expressing hMLH1 proteins. We report that expression of wild-type hMLH1 protein causes an approx. 19-fold increase in mutation rates. The mutator phenotype was due to the ability of hMLH1 protein to interact with bacterial MutL and MutS proteins, thereby interfering with
INTRODUCTION
Hereditary non-polyposis colorectal cancer (HNPCC), an autosomal dominant tumour-predisposing condition, is caused by deficient DNA mismatch repair (MMR). Six human MMR genes have been identified that, when mutated in the germ line, cause susceptibility to this syndrome. The database established by the International Collaborative Group (ICG) on HNPCC (http:\\www.nfdht.nl) has led to the characterization of more than 300 mutations. The majority of these mutations affect the human MutL homologue 1 (hMLH1) (approx. 60 %), human MutS homologue 2 (hMSH2) (approx. 35 %) and 6 (MSH6) (approx. 5 %) genes [1] [2] [3] [4] [5] . A variety of nonsense, mis-sense and splicing mutations have been identified in the hMLH1 gene from HNPCC families with clinical features meeting the ' Amsterdam 1 criteria ' or ' Amsterdam 2 criteria ', which includes extracolonic neoplasms associated with Lynch II syndrome, a hereditary predisposition to the development of cancer (specifically of the breast, colon, ovary, pancreas, uterine and gastric systems) [6] . Moreover, a number of DNA alterations have been reported in hMLH1 from kindreds with tumour predisposition not fulfilling these criteria [7] . Because of the large and increasing number of MMR gene mutations, and the absence of correlation between genotype and phenotype in most of MMR gene mutations, development of biochemical or genetic systems to test mutated MMR gene mutations may be extremely useful in the management and counselling of HNPCC patients.
The evolutionary conserved hMLH1 protein is homologous with the Escherichia coli MutL gene product, which is involved in two pathways for DNA MMR. The first pathway, methylAbbreviations used : FEN1, flap structure-specific endonuclease 1 ; GHL, gyrase b/hsp90/MutL ; hMLH1, human MutL homologue 1 ; hMSH2 and hMSH6, human MutS homologues 2 and 6 ; HNPCC, hereditary non-polyposis colon cancer ; hsp90, heat-shock protein 90 ; IPTG, isopropyl β-D-thiogalactoside ; MMR, mismatch repair ; NER, nucleotide excision repair ; Ni-NTA, Ni 2 + -nitrilotriacetate ; ORF, open reading frame ; PCNA, proliferating-cell nuclear antigen ; PMS1, postmeiotic segregation increased 1 ; RFC, replication factor C ; RPA, replication protein A ; S93G (etc.), Ser 93 Gly mutation (etc.). 1 To whom correspondence should be addressed (e-mail fsc!unicz.it).
the formation of complexes between MMR proteins and mismatched DNA. Conversely, expression of proteins encoded by alleles deriving from hereditary-non-polyposis-colon-cancer (HNPCC) families decreases mutation rates, depending on the specific amino acid substitutions. These effects parallel the MutLand MutS-binding and ATP-binding\hydrolysis activities of the mutated proteins.
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directed MMR, enhances the fidelity of chromosomal replication 100-1000 fold and requires the concerted action of the MutS, MutH and UvrD proteins [8, 9] . The second pathway, ' very short patch repair ', serves to correct G-T mispairing that arise from the spontaneous deamination of 5-methylcytosine residues [10] .
More recently, structural\functional studies have clarified some aspects of the biochemistry of the MutL protein. The MMR protein has been shown to belong to the GHL [gyrase b\heat-shock protein 90 (hsp90)\MutL] ATPase superfamily that includes DNA topoisomerase II and hsp90. MutL exists in solution as a homodimer, and ATP binding induces conformational changes promoting direct contact between the N-terminal domains of the monomers, thereby modulating interactions between MutL and other components of the repair machinery [11, 12] . The ATP binding\hydrolysis site lies in a 40 kDa N-terminal fragment of MutL that retains all of the conserved residues in the MutL family. The same region of the protein is sufficient to interact with DNA and MutS in a dynamic ternary complex [13] , and with MutH, although activation of MutH by MutL may depend also on the C-terminal region [11, 12] . The Cterminal region, which is not evolutionarily conserved, has been shown to physically interact with UvrD, a protein conferring UV-radiation resistance [14, 15] , and to induce MutL dimer formation [11, 12] . On the basis of this evidence it has been hypothesized that the ATPase activity of MutL acts as a switch to co-ordinate MMR. Significantly, mutations in the MutL family that cause deficiencies in DNA MMR and a predisposition to cancer mainly occur in the putative ATP-binding site [11] .
In eukaryotes, the homologues of the MutS and MutL proteins act in the form of heterodimers that have different mispair-recognition properties and different abilities to support MMR [16] . In baker's yeast (Saccharomyces cere isiae), MSH2 forms heterodimers with MSH6 [17, 18] , and studies of the specificity of MMR have led to the conclusion that the MSH2-MSH6 heterodimer (MutSα) primarily recognizes and corrects single base-pair mismatches, while the MSH2-MSH3 heterodimer (MutSβ) acts to correct heteroduplex DNA containing small loops formed by frameshift mutations [17] [18] [19] . The major MutL homologue is a heterodimeric complex of MLH1 and postmeiotic segregation increased 1 (PMS1 ; MutLα) in yeast [20, 21] , whereas an additional MutL activity involves an MLH1-MLH3 (MutLβ) heterodimer and acts in conjunction with MutSβ [22] . ATPdependent assembly of a ternary complex consisting of DNA mismatch and the yeast MutSα and MutLα has been demonstrated [23] . More recently, functional studies on yeast MutLα have confirmed the essential role of the ATPase domains of both MLH1 and PMS1, supporting the view that ATP induces conformational changes in the N-terminal regions that may serve to co-ordinate downstream events during DNA MMR [24] .
In human cells, hMLH1 forms a heterodimer with hPMS2 and this complex, referred to as hMutLα, has been shown to interact with the human MutS equivalent hMutSα (hMSH2-hMSH6) and replication factors [25] . Indeed, a number of other proteins have been implicated in MMR, including DNA polymerase δ, RPA (replication protein A), PCNA (proliferating-cell nuclear antigen), RFC (replication factor C), exonuclease 1, flap structure-specific endonuclease 1 [FEN1 ; ' RAD27 ' (required for cell-cycle arrest following DNA damage)] and the DNA polymerase-δ-and -ε-associated exonucleases. Eukaryotic MMR proteins have also been shown to function in other types of repair and recombination that appear distinct from MMR. MMR proteins function in these processes in conjunction with components of nucleotide excision repair (NER) and recombination [16] .
On the basis of these data and on the high degree of similarity in structure and function between the MutL homologues in both eukaryotes and prokaryotes [24, 26] , we tested the effect of expression of hMLH1 proteins in MMR-proficient and -deficient E. coli cells on DNA repair, in an attempt to develop a simple genetic assay to screen hMLH1 alleles.
EXPERIMENTAL

Bacterial strains and growth conditions
E. coli strains used in this study were : SMR506 (rif r thi − proB − Fh), the congenic derivatives SMR3406 (mutS201 :: Tn5) and SMR3428 (mutL211 :: Tn5), which were a gift from Dr S. M. Rosenberg (Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, U.S.A.). The strain DH5α [F − Φ80d lacZ∆M15 endA1 recA1 hsdR17 supE44 thi-1 λ − gyrA96 ∆(lacZYA-argF ) U169] was used in cloning procedures and the strain BL21 λDE3 (F − ompT r B − m B − ) was used to overexpress recombinant proteins [27] . E. coli strains were grown in Luria-Bertani broth or Luria-Bertani agar supplemented with 50 µg\ml ampicillin when requested. MacConkey-lactose agar was used in the test of Lac papillae [28] (the test of Lac papillae, to assay mutator phenotype, is performed by counting papillae in a zone of clearing around the spot of dry nalidixic acid dropped on 0.1 ml of saturated culture spread on Luria-Bertani plates).
Plasmids and cloning procedures
The entire open reading frame (ORF) of hMLH1 was a gift of Professor Dr Josef Jiricny, Medizinische Fakulta$ t, Institut fu$ r Medizinische Radiobiologie (IMR) der Universita$ t Zu $ rich und des Paul Scherrer Instituts, Zurich, Switzerland, and was cloned between the BamHI and KpnI sites of pUC19 (pUMLH1 wildtype) translationally in-frame with the start codon of the vector lacZ, under control of the inducible lac promoter. Site-directed mutagenesis of the hMLH1 cDNA insert was obtained using the QuickChange Kit (Stratagene). The pUMLH1 mutants were generated with the following primers : For pUMLH1 S93G : forward : 5h-CCTTTGAGGATTTAGC-CGGTATTTCTACCTATGGC-3h ; reverse : 5h-GCCATAGG-TA GAAATACCGGCTAAATCCTCAAAGG-3h For pUMLH1 K84E : forward : 5h-TCACTACTAGTGAACT-GCAGTCCTTT-3h ; reverse : 5h-AAAGGACTGCAGTTCAC-TAGTAGTGA-3h
For pUMLH1 V716M : forward : 5h-TGGAAGTGGACTAT-GGAACACATTGT-3h ; reverse : 5h-ACAATGTGTTCCATA-GTCCACTTCCA-3h
The strain DH5α was used in cloning procedures.
All these constructs were verified by DNA sequencing to confirm that both the mutation and the remainder of the hMLH1 cDNA insert were correct.
The plasmids pMQ393 and pMQ395, expressing histidinetagged MutL and MutS proteins used in the present study were a gift from Professor Martin G. Marinus, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, U.S.A. [29] .
Lac
T reversion test
The E. coli strains SMR506 (rif r thi − proB − Fh) and the congenic derivatives SMR3406 (mutS201 :: Tn5) and SMR3428 (mut-L211 ::Tn5) were transfected with plasmids engineered to express wild-type (pUMLH1) or mutated (pUMLH1 S93G, pUMLH1 K84E and pUMLH1 V716M) hMLH1 proteins. The Lac papillae reversion test was performed essentially as described in [28] . Lac + reversion rates were determined by fluctuation analysis as previously described [30] .
Western-blot analysis
E. coli strain SMR506 was transfected with pUMLH1 wild-type, pUMLH1 S93G, pUMLH1 K84E, pUMLH1 V716M or control vector pUC19, and grown to early exponential phase. After incubation with 1 mM isopropyl β--thiogalactoside (IPTG) for 2 h at 37 mC, bacteria were lysed by sonication in buffer H (20 mM Hepes\100 mM KCl\5 mM MgCl # \1 mM CaCl # \0.1 % Nonidet P40\1 mM PMSF, pH 7.1), and protein products were purified from the soluble-extract fraction by centrifugation for 12 min at 12 000 g. The proteins were electrophoresed on SDS\10 %-PAGE gels and transferred to a nitrocellulose filter (Immobilon TM P ; Millipore). After addition of the blocking mixture [5 % (w\v) BSA in PBS, pH 7.4], the membrane was incubated with a 1 : 200 dilution of rabbit anti-(hMLH1) antibody (Santa Cruz Biotechnology) for 2 h at room temperature. Bound antibody was detected with anti-rabbit horseradish-peroxidaseconjugated secondary antibody (1 : 5000) and by enhanced chemiluminescence (Santa Cruz Biotechnology).
MutL-hMLH1 and MutS-hMLH1 interaction in vitro
E. coli strains SMR506 harbouring pUMLH1 wild-type, pUMLH1 S93G, pUMLH1 K84E, pUMLH1 V716M or pUC19, and BL21 λDE3 harbouring pMQ393 or pMQ395 plasmids were grown to early exponential phase and induced with IPTG as described above. Bacteria were lysed by sonication in buffer H, and protein products were purified from the soluble-extract fraction by centrifugation. The supernatants normalized to the amounts of the recombinant proteins [histidine-tagged MutL (from plasmid pMQ393) or MutS (from plasmid pMQ395)] were incubated with Ni# + -nitrilotriacetate (Ni-NTA)-agarose for 2 h at 4 mC. Histidine-tagged proteins were collected by centrifugation, washed four times with buffer H and incubated for 2 h at 4 mC with the supernatants from bacteria expressing pUMLH1 wild-type, pUMLH1 S93G, pUMLH1 K84E, pUMLH1 V716M or control vector pUC19, normalized to the amount of expressed recombinant proteins. Samples were centrifuged and washed four times with the buffer H before addition of SDS\PAGE sample buffer. The samples were then heated at 95 mC and loaded on to a SDS\10 %-PAGE gel.
ATP binding/hydrolysis assay
E. coli strain SMR506 harbouring pUMLH1 wild-type, pUMLH1 S93G, pUMLH1 K84E, pUMLH1 V716M or pUC19 were grown to early-exponential phase and induced with IPTG. Bacteria were then lysed by sonication in buffer A [50 mM Tris\HCl (pH 7.5)\150 mM NaCl\1 % Nonidet P40\protease inhibitor cocktail (Roche)] ; after centrifugation, the supernatant was incubated with mouse anti-(hMLH1) (BD Biosciences Pharmingen, San Diego, CA, U.S.A.) for 2 h at 4 mC. [31] . Nitrocellulose (Hybond-C ; Amersham) was used to retain all proteins, including free and nucleotideassociated proteins. Nylon (Hybond-Nj ; Amersham) was used to retain free nucleotides. Filter papers were pre-soaked in the reaction buffer and stacked on to a 96-well dot-blot apparatus in the order : 3 MM gel-blot paper, nylon and nitrocellulose membrane. hMLH1 proteins were affinity-purified from the E. coli extracts using mouse anti-(hMLH1) and Protein A-Sepharose as described above. After centrifugation and washing with buffer A, ATP binding was performed in the same buffer system (buffer B) used for ATP hydrolysis, and 0.1 mM [α-$#P]ATP or [γ-$#P]ATP in parallel at room temperature. Samples (25 µl) were withdrawn and applied to the blot apparatus at various time points from 2 to 60 min. The steady state was reached in 15 min. Following drawing of the samples through the membranes by vacuum, wells were washed by adding 100 µl of the reaction buffer. The membranes were removed and air-dried, and $#P-free and proteinassociated nucleotides were quantified using the PhosphorImager (Molecular Dynamics) system.
RESULTS
Effects of expression in E. coli of hMLH1 alleles on MMR activity
A simple genetic system was developed to test the effect of overexpression of wild-type or mutated hMLH1 proteins on MMR in Figure 1 Western-blot analysis of recombinant hMLH1 proteins E. coli cells (strain SMR506) expressing wild-type hMLH1 (' wt '), mutated hMLH1(S93G) (' S93G '), hMLH1(K84E) (' K84E ') and hMLH1(V716M) (' V716M ') or control vector (' control '), were induced with IPTG and lysed by sonication to recover protein products from the solubleextract fraction by centrifugation. Proteins were electrophoresed on an SDS/10 % -PAGE gel and analysed by Western blot using a rabbit anti-hMLH1 antibody. E. coli. The system relies on congenic MMR-proficient or MMRdeficient E. coli strains carrying a lac j1 frameshift mutation (CCC to CCCC) within a lacI-lacZ fusion residing on an Fh episome. The mutation is polar on lacZ, making the cell Lac − . Lac + reversion mutations can restore the reading frame by deletion or addition anywhere between two out-of-frame stop codons in a window of about 70 bp. In many cases, Lac + revertants are detected as a consequence of k1 deletions in the small nucleotide repeat [28] . The E. coli strains were transfected with plasmids expressing wild-type or mutated hMLH1 proteins. The vectors were pUC19 derivatives containing the coding sequences from wild-type hMLH1 or mutated hMLH1(S93G), hMLH1(K84E), hMLH1(V716M) alleles translationally in frame with the start codon of the vector lacZ, under control of the inducible lac promoter (see the Experimental section) (S93G, as an example, means a Ser*$ Gly mutation). Because of the presence of many codons in the hMLH1 sequence, which are poorly translated in E. coli, expression of the heterologous protein in bacteria upon IPTG induction was tested by Westernblot analysis (Figure 1) . A polyclonal antibody directed against the wild-type hMLH1 protein detected comparable amounts of specific peptides of the expected molecular mass in all transfected strains that were not present in the untransfected cells. Since it is known that the MMR repair capacity is repressed in nutritionally stressed bacteria by depletion of MutS and MutH proteins [32, 33] , the Lac reversion test was performed under nonselective growth conditions in order to detect spontaneous (non-adaptive) reversions. The results of this analysis (Table 1) indicated that reversion frequencies to Lac + were approx. 19-fold higher in MMR-proficient E. coli cells harbouring the recombinant plasmid expressing the wild-type hMLH1 protein than in a control strain transfected by a vector plasmid. A comparable increase in mutation rates (about 10-fold) was detected in E. coli cells expressing the mutated hMLH1(V716M) protein, and even more (about 31-fold) in bacteria expressing hMLH1(K84E). Conversely, the increase was not detected in E. coli cells producing the mutated hMLH1(S93G) protein.
We also measured Lac + reversion rates in MMR-deficient E. coli strains transfected with the different hMLH1 expressing plasmids (Table 1) . At variance with the MMR-proficient strain, MutS-deficient bacteria, transfected with the vector plasmid or with the different hMLH1-expressing plasmids, all exhibited higher rates of Lac + reversion with similar frequencies (about 250-fold higher than in the Mut + control strain). Similar results were obtained with MutL-deficient bacteria. However, these cells exhibited a lower increment in mutation rates (about 19-fold higher than in the Mut + control strain) that was the same either in the absence or in the presence of wild-type hMLH1 or mutated hMLH1(S93G) or hMLH1(V716M) proteins. This increment was comparable with that observed in Mut + strain when transformed with the wild-type-hMLH1-expressing plasmid. Note that this value was a little higher (29-fold) in MutL-deficient bacteria expressing hMLH1(K84E). Table 1 . † The different abilities of wild-type and mutated hMLH1 proteins to bind either histidinetagged MutL or MutS, or to bind/hydrolyse ATP are represented as symbols (j, k). The assignment of these symbols is consistent with the quantitative analyses shown in Figures 2-4 . 
Figure 3 Interaction of hMLH1 proteins with histidine-tagged MutS
hMLH1 interferes with the E. coli MMR machinery
The results described above suggested that expression of hMLH1 proteins interfered with the activity of the endogenous MMR machinery. We hypothesized that wild-type and several hMLH1 proteins might interact with specific bacterial MMR protein(s), thereby subtracting them from the damage lesions. To test this hypothesis we analysed the ability of hMLH1 proteins to interact with E. coli MMR proteins. The interaction between hMLH1 proteins and MutL was assayed in itro by pull-down experiments (Figure 2 ). To this end, different amounts of histidine-tagged MutL protein were immobilized on Ni-NTA-agarose. Note that the histidine-tag at the N-terminus of MutL did not affect the normal activity of the protein [29] . The tagged MutL was challenged with E. coli extracts expressing wild-type or mutated hMLH1 proteins. After extensive washing, hMLH1 protein interacting with MutL was assayed by Western blotting using a rabbit anti-hMLH1 antibody (Figure 2A) . The percentage of binding activity determined by densitometric scanning of the filters is reported in Figure 2(B) . Bacterial MutL retained wildtype hMLH1 and, albeit to a lesser extent, mutated hMLH1 (V716M). The interaction of MutL with hMLH1 mutants was markedly decreased with hMLH1(K84E) (about 90 %) and to lesser extent with hMLH1(S93G) (about 70 %) compared with the wild-type hMLH1 ( Figure 2B) . The mutant at the C-terminus [hMLH1(V716M)] showed only a modest decrease in interaction (about 50 %) ( Figure 2B ). This finding explains the genetic data indicating that these proteins interfered with the E. coli MMR machinery. The effects elicited by wild-type and mutated hMLH1 proteins in the Lac + reversion test (Table 1) were associated with the different ability of the hMLH1 proteins to interact with the E. coli MutL (Figures 2A and 2B) . In fact, wild-type hMLH1 and hMLH1(V716M) interacted strongly with MutL and determined a relevant increase in mutation rates (Table 2) . Conversely, hMLH1(S93G) did not affect substantially the frequency of Lac + reversion, and, accordingly, its binding to MutL was weaker (Table 2) . However, hMLH1(K84E) increased the mutation rates and interacted with MutL with a lower affinity compared with the wild-type hMLH1 (Table 2 ). This finding suggested that hMLH1(K84E) was interacting with another component of the complex to down-regulate MMR function. Because MutL was demonstrated to be part of a dynamic ternary nucleoprotein complex with MutS and mismatched DNA, we tested by Western blotting the ability of hMLH1 proteins to interact with histidine-tagged MutS ( Figure 3A) . Figure 3(B) shows that hMLH1 binds recombinant MutS and that the interaction is considerably stronger with hMLH1(K84E) (about 3-fold) than that found with the other hMLH1 proteins. These data indicated that the mutator phenotype determined by expression of hMLH1(K84E) is dependent on its ability to interfere with bacterial MutS.
ATP-binding/hydrolysis of wild-type and mutated hMLH1 proteins
Since ATP binding modulates interactions between MutL-like proteins and other components of the repair machinery, we reasoned that the different ability of the hMLH1 proteins to interact with the E. coli MutL and MutS might be dependent on different ATP-binding\hydrolysis properties. We therefore performed an in itro ATP-binding\hydrolysis assay using E. coli extracts containing wild-type or mutated hMLH1 proteins and [α-$#P]ATP (Figure 4 ). In this assay we used conditions that eliminated endogenous ATPase activity completely, thereby allowing detection of specific activity associated to the hMLH1 proteins (see the Experimental section). This is shown in Figure 4 , where the hydrolysis product was only apparent when extracts expressing hMLH1 proteins ( Figure 4A, lanes 2-4) were used, and was absent in the control extract ( Figure 4A, lane 1) . ATPase activity was determined at different ATP concentrations ( Figure 4B ) and as a function of time ( Figure 4C ). Figure 4 shows that the ATP-hydrolysis activities were different in the hMLH1 proteins. The activity was maximal in wild-type hMLH1, moderately decreased in hMLH1(V716M) (83.3 % at 15 min of the reaction, using 0.5 mM ATP) and more markedly decreased in hMLH1(S93G) (50 %) and hMLH1(K84E) (33.3 %).
Since ATP binding must precede hydrolysis, we investigated the ATP-binding properties of the hMLH1 proteins. The results of double-filter binding assays using [α-$#P]ATP and [γ-$#P]ATP, which permits the quantification of the amounts of ATP and ADP bound to the proteins (see the Experimental section), demonstrated that decreased ATP hydrolysis of mutant hMLH1 proteins coincided with decreased ability to bind ATP ( Figure  4D ). This finding suggested that the ATPase defect is primarily due to inefficient binding of the nucleotide.
DISCUSSION
The original aim of the present study was to develop a simple genetic assay to test hMLH1 mutations from HNPCC kindreds. The high amino-acid-sequence homology between members of the MutL family prompted us to use E. coli as a control for the set-up of the assay. The sequence homology between E. coli MutL and hMLH1 is very impressive at their N-terminus, implying that the conserved N-terminal region carries out similar functions such as ATP binding\hydrolysis and interactions with other components of the repair machinery. It is not surprising that the majority of the reported mutations with dominant mutator phenotypes in E. coli MutL [34] are within the conserved N-terminal region, and that more than 50 % of mis-sense mutations found in hMLH1 of HNPCC [35] are also within this equivalent conserved region.
Expression of wild-type hMLH1 in a MMR-proficient strain of E. coli results in a moderate mutator phenotype comparable with that of a MutL-deficient strain. Expression of N-or Cterminally mutated hMLH1 alleles had variable effects : hMLH1 (S93G) did not enhance mutation rates significantly, whereas the effects produced by hMLH1(V716M) were similar to those of the wild-type hMLH1 gene. hMLH1(K84E) was the stronger mutator allele among those analysed ( Table 1 ). The ability of eukaryotic MMR proteins to interfere with the normal bacterial MMR pathway is not novel. It has been reported that expression of hMSH2, a human homologue of MutS, in E. coli causes a dominant mutator phenotype, but the interaction with the bacterial MMR proteins was not tested directly [36] . We have evidence that the mutator phenotype parallels with the ability of the hMLH1 proteins to interact with MutL and MutS in itro (Table 2) . Indeed, the N-terminal hMLH1(S93G) mutation greatly decreased (to about 30 %) the interaction with MutL (Figure 2 ), whereas hMLH1(K84E), although interacting less efficiently with MutL (about 10 %) than wild-type hMLH1, displayed the maximal MutS-binding activity (Figure 3) .
In the Lac-reversion test the E. coli mutS mutant generally exhibited a significantly stronger mutator phenotype than the mutL mutant. It has been suggested that, in the mutL cells, MutS binds to mismatches and is able to kill or remove heteroduplexes that cannot be repaired by MMR [28] . Here we show that all the hMLH1 proteins are able to interact with E. coli MutS in itro, albeit to different extents ( Figure 3 and Table 2 ). However, all hMLH1 proteins save hMLH1(K84E) did not alter the mutation rates in mutL background (Table 1 ). It is possible that the weak MutS-binding activity of wild-type hMLH1 or mutated hMLH1 (S93G) or hMLH1(V716M) proteins did not disturb substantially the function of MutS in i o. Indeed, it has been reported that, in exponentially growing bacteria, MutS is present in slight excess over MutL and MutH [32] . In contrast, hMLH1(K84E) showed a considerably stronger affinity to MutS (Figure 3 ) and caused a higher mutation rate in mutL cells (Table 1) .
These findings can be interpreted by taking into account recent results on the ATPase activity and associated structural transformations of proteins belonging to the MutL family [11, 12, 24] . The ATP-binding site of MutL is composed of constant and variable segments. The constant domain is well ordered, even in the absence of the nucleotide, and contains three of the four sequence motifs (I, II and IV) conserved in the GHL ATPase superfamily. These motifs are : helix A, strands 2 and 6 and the loop following strand 2 in MutL, and make up the adeninebinding pocket [11] . The variable domain, which consists of the so-called ATP ' lid ' (upon nucleotide association) and the L3 loop, becomes structurally ordered upon nucleotide binding. The ATP ' lid ' contains motif III (residues 91-100 in MutL and 96-105 in hMLH1) and about 20 residues which precede this site and are conserved only in the MutL family. The ATP ' lid ' and the L3 loop are sensors of the hydrolysis of γ-phosphate, and the conformational changes in the N-terminal regions of the MutL dimer may serve to modulate interactions with components of MMR machinery [12] . hMLH1 mutations K84E and S93G map within this region and affect two residues notably conserved among members of the MutL family. It is noteworthy that mutation S93G did not show any effect in an in itro MMR complementing assay [37] .
In addition to the regions directly involved in ATP binding\ hydrolysis, the members of the MutL family share several regions potentially involved in N-terminal dimerization. The L2 loop (residues 150-162 in MutL and 155-167 in hMLH1) is the only conserved region in the MutL family that is not directly associated within nucleotide binding, but instead contributes prominently to the dimer interface. L2 loop is composed of residues that become ordered following ATP binding in LN40, a 40 kDa ATPase fragment of E. coli MutL. Conservation of this interface may account for the ability of wild-type hMLH1 to interact with E. coli MutL (Figure 2) . Mutation S93G, which is located within a region (the ATP ' lid ') that is not directly involved in ATP hydrolysis, severely affects ATP binding and hydrolysis ( Figure  4) , and markedly decreases its ability to bind MutL (Figure 2 ). Defective ATP binding is expected to prevent structuring of the interface. In fact, mutation G98A mapping close to S93G dramatically decreases ATP binding and the ability of yeast MLH1 to form heterodimers with PMS1 [24] .
Similarly, mutation K84E also affects ATP binding (Figure 4 ) and decreases the MutL-binding activity of the protein ( Figure  2) . Indeed, there is evidence that the conserved K84 (Lys)%) residue, which corresponds to K79 in E. coli MutL, is directly involved in ATP binding by donating hydrogen bonds to the β-phosphate residue [12] . However, the phenotype displayed by K84E in the Lac reversion test is very different with respect to that of S93G (Table 1) . Intriguingly, K84E enhances the ability of hMLH1 to interact with MutS ( Figure 3 ). This unexpected property accounts for the strong mutator phenotype that is associated with hMLH1(K84E) expression in E. coli. To date, there is no evidence that this residue participates in the interaction with MutS. Even though the molecular basis for the interaction between MutS and MutL is elusive on the basis of crystallographic studies, the candidate region for this interaction is an interface that is composed mainly of the two L45 loops o' L45 ' stands for loop 45 ; it is one of the five loops (L1, L2, L3, L45 and the ATP lid) of the LN40-adenosine 5h-[β,γ-imido]-triphosphate complexq. Formation of this interface depends on both nucleotide binding and association of the N-terminal region of MutL.
In conclusion, different N-terminal mis-sense mutations in hMLH1 are predicted to give different results in the E. coli assay, depending on their ability to interact with the components of the bacterial MMR system (Table 2) . Testing these hMLH1 mutations in this simple genetic system would be therefore useful for genetic counselling of HNPCC kindreds by identifying defective alleles.
